Literature DB >> 21407001

Citalopram-induced parkinsonian syndrome: case report.

Vladimir Miletić1, Maja Relja.   

Abstract

OBJECTIVES: To draw attention on citalopram as a possible cause of movement disorders.
METHODS: Case report of a patient with sudden-onset bilateral parkinsonian syndrome after administration of citalopram.
RESULTS: We describe a 67-year-old woman who developed sudden-onset bilateral rigidity, bradykinesia, resting and postural tremor, and typical parkinsonian gait 2 weeks after citalopram was administered. After discontinuation of citalopram, full recovery was observed, with a 4/108 score on the motor subscale of the Unified Parkinson Disease Rating Scale. Use of the Naranjo Adverse Drug Reactions Probability Scale indicated a probable (score of 8) adverse reaction of sudden-onset parkinsonism associated with citalopram consumption.
CONCLUSION: Physicians should be aware of possible parkinsonism as adverse reaction in patient taking citalopram because recognition and appropriate management can enable proper treatment and prevent serious adverse outcomes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21407001     DOI: 10.1097/WNF.0b013e318210ea3e

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN: 0362-5664            Impact factor:   1.592


  4 in total

1.  Citalopram-induced hyponatraemia and parkinsonism: potentially fatal side-effects not to be missed.

Authors:  Negin Damali Amiri; Nishan Wijenaike
Journal:  BMJ Case Rep       Date:  2014-11-12

2.  A Case of SSRI Induced Irreversible Parkinsonism.

Authors:  Siddharth Dixit; Shahbaj A Khan; Sudip Azad
Journal:  J Clin Diagn Res       Date:  2015-02-01

3.  Parkinson's Disease and Its Management: Part 1: Disease Entity, Risk Factors, Pathophysiology, Clinical Presentation, and Diagnosis.

Authors:  George DeMaagd; Ashok Philip
Journal:  P T       Date:  2015-08

4.  Acute dystonia due to citalopram treatment: a case series.

Authors:  S Mohammad Moosavi; Mahshid Ahmadi; Mani B Monajemi
Journal:  Glob J Health Sci       Date:  2014-10-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.